Study of Single Ascending Dose, Food Effects and Drug-Drug Interactions of ACC017 Tablets in Healthy Adult Participants in China: A Single-center, Randomized, Double-blind, Placebo-controlled, Two-Stage Trial
Latest Information Update: 23 Oct 2024
At a glance
- Drugs ACC 017 (Primary) ; Emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Jiangsu Aidea Pharmaceutical
Most Recent Events
- 28 Feb 2024 New trial record